Sex-specific associations between metabolic hormones, severe mental disorders and antipsychotic treatment

Psychoneuroendocrinology - Tập 146 - Trang 105927 - 2022
Ingrid T. Johansen1, Nils Eiel Steen1, Linn Rødevand1, Maren C.F. Werner1, Synve H. Lunding1, Gabriela Hjell1,2, Monica B.E.G. Ormerod1, Ingrid Agartz1,3,4, Ingrid Melle1, Trine V. Lagerberg1, Mari Nerhus1,5, Ole A. Andreassen1
1NORMENT Centre, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway
2Department of Psychiatry, Ostfold Hospital, Graalum, Norway
3Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway
4Centre for Psychiatric Research, Department of Clinical Neuroscience, Karolinska Institute & Stockholm Health Care Services, Stockholm Region, Stockholm, Sweden
5Akershus University Hospital, Division of Mental Health Services, Department for Special Psychiatry, Lorenskog, Norway

Tài liệu tham khảo

Abel, 2010, Sex differences in schizophrenia, Int. Rev. Psychiatry, 22, 417, 10.3109/09540261.2010.515205 Addington, 1990, A depression rating scale for schizophrenics, Schizophr. Res., 3, 247, 10.1016/0920-9964(90)90005-R American Psychiatric Association, 2000 Baptista, 2002, Are leptin and cytokines involved in body weight gain during treatment with antipsychotic drugs?, Can. J. Psychiatry, 47, 742, 10.1177/070674370204700805 Baptista, 2000, Body weight gain after administration of antipsychotic drugs: correlation with leptin, insulin and reproductive hormones, Pharmacopsychiatry, 33, 81, 10.1055/s-2000-8451 Baptista, 2002, Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives, Pharmacopsychiatry, 35, 205, 10.1055/s-2002-36391 Bartoli, 2015, Second-generation antipsychotics and adiponectin levels in schizophrenia: a comparative meta-analysis, Eur. Neuropsychopharmacol., 25, 1767, 10.1016/j.euroneuro.2015.06.011 Bartoli, 2015, Plasma adiponectin levels in schizophrenia and role of second-generation antipsychotics: a meta-analysis, Psychoneuroendocrinology, 56, 179, 10.1016/j.psyneuen.2015.03.012 Bartoli, 2017, Benefits and harms of low and high second-generation antipsychotics doses for bipolar depression: a meta-analysis, J. Psychiatr. Res., 88, 38, 10.1016/j.jpsychires.2016.12.021 Birkeland, 1993, Level of sex hormone-binding globulin is positively correlated with insulin sensitivity in men with type 2 diabetes, J. Clin. Endocrinol. Metab., 76, 275 Birkenaes, 2009, Hormonal markers of metabolic dysregulation in patients with severe mental disorders after olanzapine treatment under real-life conditions, J. Clin. Psychopharmacol., 29, 109, 10.1097/JCP.0b013e31819b95fc Bobes, 2007, Quality of life in schizophrenia patients, Dialog-. Clin. Neurosci., 9, 215, 10.31887/DCNS.2007.9.2/jbobes Bradley, 2010, A systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: implications for mortality, J. Psychopharmacol., 24, 91, 10.1177/1359786810385491 Brzezinski-Sinai, 2020, Schizophrenia and sex hormones: what is the link?, Front Psychiatry, 11, 693, 10.3389/fpsyt.2020.00693 Chen, 2021, Role of appetite hormone dysregulation in the cognitive function among patients with bipolar disorder and major depressive disorder, World J. Biol. Psychiatry, 22, 428, 10.1080/15622975.2020.1819566 Correll, 2007, Does antipsychotic polypharmacy increase the risk for metabolic syndrome?, Schizophr. Res., 89, 91, 10.1016/j.schres.2006.08.017 Craddock, 2009, Psychosis genetics: modeling the relationship between schizophrenia, bipolar disorder, and mixed (or "schizoaffective") psychoses, Schizophr. Bull., 35, 482, 10.1093/schbul/sbp020 De Hert, 2011, Metabolic and cardiovascular adverse effects associated with antipsychotic drugs, Nat. Rev. Endocrinol., 8, 114, 10.1038/nrendo.2011.156 Devdhar, 2007, Hypothyroidism, Endocrinol. Metab. Clin. North Am., 36, 595, 10.1016/j.ecl.2007.04.008 Devereaux, 2014, Hyperthyroidism and thyrotoxicosis, Emerg. Med. Clin. North Am., 32, 277, 10.1016/j.emc.2013.12.001 Divac, 2014, Second-generation antipsychotics and extrapyramidal adverse effects, Biomed. Res. Int., 2014, 10.1155/2014/656370 Elias, 2007, Testosterone for schizophrenia, Cochrane Database Syst. Rev., 10.1002/14651858.CD006197.pub2 Feldman, 2013, Neuropsychiatric manifestations of thyroid disease, Endocrinol. Metab. Clin. North Am., 42, 453, 10.1016/j.ecl.2013.05.005 First, M.B., Spitzer, R.L., Gibbon, M., Williams, J.B.W., 1995. Structured Clinical Interview for DSM-IV Axis I Disorders: Patient Edition (SCID-P), Version 2. Biometrics Research, New York State Psychiatric Institute, New York. Goldstein, 2007, Hypothalamic abnormalities in schizophrenia: sex effects and genetic vulnerability, Biol. Psychiatry, 61, 935, 10.1016/j.biopsych.2006.06.027 Grajales, 2019, Second-generation antipsychotics and dysregulation of glucose metabolism: beyond weight gain, Cells, 8 Greenhalgh, 2017, Meta-analysis of glucose tolerance, insulin, and insulin resistance in antipsychotic-naive patients with nonaffective psychosis, Schizophr. Res., 179, 57, 10.1016/j.schres.2016.09.026 Haack, 2009, Sex-specific differences in side effects of psychotropic drugs: genes or gender?, Pharmacogenomics, 10, 1511, 10.2217/pgs.09.102 Halbreich, 2003, Hormonal aspects of schizophrenias: an overview, Psychoneuroendocrinology, 28, 1 Jonsdottir, 2010, Medication adherence in outpatients with severe mental disorders: relation between self-reports and serum level, J. Clin. Psychopharmacol., 30, 169, 10.1097/JCP.0b013e3181d2191e Kay, 1987, The positive and negative syndrome scale (PANSS) for schizophrenia, Schizophr. Bull., 13, 261, 10.1093/schbul/13.2.261 Kornetova, 2020, Body fat parameters, glucose and lipid profiles, and thyroid hormone levels in schizophrenia patients with or without metabolic syndrome, Diagn. (Basel), 10 Labad, 2019, The role of cortisol and prolactin in the pathogenesis and clinical expression of psychotic disorders, Psychoneuroendocrinology, 102, 24, 10.1016/j.psyneuen.2018.11.028 Lally, 2015, Antipsychotic medication in schizophrenia: a review, Br. Med. Bull., 114, 169, 10.1093/bmb/ldv017 Lange, 2017, How gender affects the pharmacotherapeutic approach to treating psychosis - a systematic review, Expert Opin. Pharm., 18, 351, 10.1080/14656566.2017.1288722 Leucht, 2009, Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis, Lancet, 373, 31, 10.1016/S0140-6736(08)61764-X Lindstrom, 2017, Maintenance therapy with second generation antipsychotics for bipolar disorder - a systematic review and meta-analysis, J. Affect Disord., 213, 138, 10.1016/j.jad.2017.02.012 Lis, 2020, Impaired hormonal regulation of appetite in schizophrenia: a narrative review dissecting intrinsic mechanisms and the effects of antipsychotics, Psychoneuroendocrinology, 119, 10.1016/j.psyneuen.2020.104744 Meier, 2004, Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin, Clin. Chem., 50, 1511, 10.1373/clinchem.2004.032482 Misiak, 2018, Testosterone, DHEA and DHEA-S in patients with schizophrenia: a systematic review and meta-analysis, Psychoneuroendocrinology, 89, 92, 10.1016/j.psyneuen.2018.01.007 Misiak, 2019, Appetite regulating hormones in first-episode psychosis: a systematic review and meta-analysis, Neurosci. Biobehav. Rev., 102, 362, 10.1016/j.neubiorev.2019.05.018 Misiak, 2021, Thyroid hormones in persons with schizophrenia: a systematic review and meta-analysis, Prog. Neuropsychopharmacol. Biol. Psychiatry, 111, 10.1016/j.pnpbp.2021.110402 Mucci, 2017, Primary and persistent negative symptoms: concepts, assessments and neurobiological bases, Schizophr. Res., 186, 19, 10.1016/j.schres.2016.05.014 Newcomer, 2005, Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review, CNS Drugs, 19, 1 Okita, 2014, Second-generation antipsychotics and bone turnover in schizophrenia, Schizophr. Res., 157, 137, 10.1016/j.schres.2014.05.009 Pradhan, 2014, Sex differences in the metabolic syndrome: implications for cardiovascular health in women, Clin. Chem., 60, 44, 10.1373/clinchem.2013.202549 Qaid, 2016, Role of insulin and other related hormones in energy metabolism - a review, Cogent Food Agric., 2 Redman, 2021, Levels of prolactin and testosterone and associated sexual dysfunction and breast abnormalities in men with schizophrenia treated with antipsychotic medications, J. Psychiatr. Res., 143, 50, 10.1016/j.jpsychires.2021.08.022 Ringen, 2008, Illicit drug use in patients with psychotic disorders compared with that in the general population: a cross-sectional study, Acta Psychiatr. Scand., 117, 133, 10.1111/j.1600-0447.2007.01135.x Romanova, 2022, Psychotropic drug effects on steroid stress hormone release and possible mechanisms involved, Int. J. Mol. Sci., 23 Rush, 1986, The inventory for depressive symptomatology (IDS): preliminary findings, Psychiatry Res., 18, 65, 10.1016/0165-1781(86)90060-0 Rush, 1996, The inventory of depressive symptomatology (IDS): psychometric properties, Psychol. Med., 26, 477, 10.1017/S0033291700035558 Seeman, 2002, The role of sex hormones in psychopathology, Prim. Care: Clin. Off. Pract., 29, 171, 10.1016/S0095-4543(03)00080-0 Seeman, 2009, Secondary effects of antipsychotics: women at greater risk than men, Schizophr. Bull., 35, 937, 10.1093/schbul/sbn023 Seeman, 2010, Schizophrenia: women bear a disproportionate toll of antipsychotic side effects, J. Am. Psychiatr. Nurses Assoc., 16, 21, 10.1177/1078390309350918 Seeman, 2020, Men and women respond differently to antipsychotic drugs, Neuropharmacology, 163, 10.1016/j.neuropharm.2019.05.008 Seeman, 2002, Atypical antipsychotics: mechanism of action, Can. J. Psychiatry, 47, 27, 10.1177/070674370204700106 Steen, 2011, Sex-specific cortisol levels in bipolar disorder and schizophrenia during mental challenge--relationship to clinical characteristics and medication, Prog. Neuropsychopharmacol. Biol. Psychiatry, 35, 1100, 10.1016/j.pnpbp.2011.03.008 Steen, 2011, Increased systemic cortisol metabolism in patients with schizophrenia and bipolar disorder: a mechanism for increased stress vulnerability?, J. Clin. Psychiatry, 72, 1515, 10.4088/JCP.10m06068yel Stubbs, 2016, Are leptin levels increased among people with schizophrenia versus controls? A systematic review and comparative meta-analysis, Psychoneuroendocrinology, 63, 144, 10.1016/j.psyneuen.2015.09.026 Subramaniam, 2019, Psychotropic medication effects on cortisol: Implications for research and mechanisms of drug action, Schizophr. Res., 213, 6, 10.1016/j.schres.2019.06.023 Talih, 2007, Anabolic steroid abuse: psychiatric and physical costs, Cleve Clin. J. Med., 74, 341, 10.3949/ccjm.74.5.341 Vedal, 2018, Free thyroxine and thyroid-stimulating hormone in severe mental disorders: a naturalistic study with focus on antipsychotic medication, J. Psychiatr. Res., 106, 74, 10.1016/j.jpsychires.2018.09.014 Vedal, 2019, Adipokine levels are associated with insulin resistance in antipsychotics users independently of BMI, Psychoneuroendocrinology, 103, 87, 10.1016/j.psyneuen.2019.01.001 Wu, 2007, Sex difference in effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia, J. Clin. Psychopharmacol., 27, 374, 10.1097/JCP.0b013e3180cac8db Young, 1978, A rating scale for mania: reliability, validity and sensitivity, Br. J. Psychiatry, 133, 429, 10.1192/bjp.133.5.429 Zhu, 2020, Functional status of hypothalamic-pituitary-thyroid and hypothalamic-pituitary-adrenal axes in hospitalized schizophrenics in Shanghai, Front Psychiatry, 11, 65, 10.3389/fpsyt.2020.00065